Weekly Recap | Cerebras -19.5%, lock-up and chip fears weigh
I'm LongbridgeAI, I can summarize articles.Cerebras fell 19.5% this week to close at $166.43, while the S&P 500 slipped 0.27%, leaving the stock lagging the benchmark by roughly 19.23 percentage points. Monday’s open at $204.50 failed to hold, and Tuesday’s intraday high of $214.00 marked the top before three straight down days. Friday’s session bottomed at $165.22 and the stock closed at $166.43. Weekly amplitude came to 23.85%, with volume running well above normal: average daily volume of about 10.66m shares was 93.
The Week
Cerebras fell 19.5% this week to close at $166.43, while the S&P 500 slipped 0.27%, leaving the stock lagging the benchmark by roughly 19.23 percentage points. Monday’s open at $204.50 failed to hold, and Tuesday’s intraday high of $214.00 marked the top before three straight down days. Friday’s session bottomed at $165.22 and the stock closed at $166.43. Weekly amplitude came to 23.85%, with volume running well above normal: average daily volume of about 10.66m shares was 93.63% higher than the median.
Key Events
The week’s story was built around the IPO lock-up expiry and OpenAI chip headlines. On 30 September, Cerebras fell more than 8% intraday as roughly 19.4m unlocked shares hit the market, while reports around OpenAI’s chip plans added competitive concerns; the Class A shares closed down 8.21%. A pre-market and overnight bounce on 1 October faded into Thursday’s close, and Friday’s session saw another push lower with the stock down nearly 5% intraday before finishing at $166.43. Some put options jumped about 933% on Wednesday and another 266% on Thursday, pointing to heavy short-term hedging. Early on 3 October, OpenAI’s Sam Altman called Cerebras a close partner with deep engagement, and the stock ticked higher in after-hours trading.
Analyst Ratings
As of 2 October, 13 institutions cover Cerebras: 8 buy, 3 overweight, and 2 no opinion, with no hold, underweight, or sell ratings. The consensus rating is strong buy, and the consensus target of $291.64 sits about 75.23% above the latest close of $166.43. Individual targets range from $209.00 to $330.00, showing a wide spread. Within the semiconductor industry, Cerebras ranks 30th out of 78 names; the industry averages 14 covering institutions with a median of 9. Freedom Capital Markets upgraded the stock to buy on 2 October and set a $209 target.
The Week Ahead
On the macro calendar, 5 October brings the US S&P Global services PMI final (prior 58.7) and the ISM non-manufacturing PMI (prior 55.4, consensus 55). On 6 October, the US international trade balance (prior -$88.6, consensus -$102) and goods trade balance (prior -$132.6) are due. 7 October includes the weekly EIA crude oil and Cushing inventory reports. With this week’s lock-up overhang and competitive worries still working through the tape, the focus turns to whether Cerebras can stabilise near $165 and how services-sector data shapes risk appetite across semiconductors.
In Short
Cerebras closed the week with a tug-of-war between the rating picture and near-term flows. The sell-side skews positive: 11 of 13 covering institutions rate it buy or overweight, with a strong-buy consensus and a target about 75% above spot. Yet the latest session’s flow data show large-lot money as a net seller, with inflows of about 15.29m against outflows of about 31.46m. Price action also softened: the close of $166.43 sits below the 20-day moving average of $194.11 and the 60-day of $200.48, and it is not far from the 60-day range low of $162.35. The next test is whether lock-up supply keeps dragging on the stock, whether Altman’s partnership language gets follow-through, and how chip-sector risk appetite reacts to the macro data ahead.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.
